California’s Safe Drinking Water and Toxic Enforcement Act of 1986, commonly known as Proposition 65, requires businesses to warn residents about significant exposures to chemicals that cause cancer, birth defects or other reproductive harm. The Office of Environmental Health Hazard Assessment (OEHHA), the agency charged with implementing Proposition 65, maintains and updates a list of these chemicals – a list that includes nearly 900 chemicals and continues to grow. This webinar will provide an overview of recent and potential Proposition 65 developments to assist dietary supplement and food companies with compliance and help mitigate the risk of litigation.
Purchase on demand from Natural Product INSIDER's website.
Under Proposition 65, companies doing business in California must provide a “clear and reasonable” warning to consumers about exposures to listed chemicals, unless the exposures do not exceed warning threshold levels. Because Proposition 65 is enforced primarily through private litigation, having a strong compliance plan in place reduces the risk of costly and time-consuming lawsuits. However, OEHHA recently adopted changes to its clear and reasonable warning regulations and continues add additional chemicals to the list. Further, pending litigation and possible regulatory changes may significantly lower the warning threshold for lead, which is perhaps the most ubiquitous and frequently litigated chemical on the Proposition 65 list. This webinar will assist companies in identifying current and future liability and litigation risks, discuss the future of Proposition 65, and provide companies with practical tips for compliance.
ORIGINAL DATE: Tuesday, December 6, from 2 – 4 pm Eastern
Learn more about:
- The current litigation and regulatory environment, including recent changes to the clear and reasonable warning regulations
- Potential changes to the safe harbor for lead following Environmental Law Foundation v. Beech-Nut
- New chemical listings on the horizon
- Compliance considerations for companies
Moderated by CRN's Rend A-Mondhiry, Esq., Associate General Counsel
With:
- Trenton H. Norris, Senior Partner, Arnold & Porter LLP
- Paul Bolar, VP, Regulatory Affairs Pharmavite LLC
- James R. Coughlin, Ph.D., CFS, President & Founder Coughlin & Associates: Consultants in Food/Nutritional/Chemical Toxicology & Safety
- Anthony J. Cortez, Shareholder, Greenberg Traurig, LLP